TORRANCE, Calif., Feb. 13, 2024 /PRNewswire/ — MISAA and IOS are pleased to announce they have commenced the FDA certification process for the patent pending, tacrolimus immunosuppressant in vitro diagnostic, Tac-Assay. MISAA, LLC. (www.misaallc.com), a subsidiary of Intelligent Optical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.